A series of thiazole benzenesulfonamide-substituted 3-pyridylethanolamines was prepared and evaluated for their human beta(3) adrenergic receptor agonist activity. Incorporation of aryl and heteroaryl substitution in the 4-position of the thiazole ring resulted in a number of highly potent and selective beta(3) agonists. Results of preliminary in vivo evaluation of several of these compounds is described. (C) 2000 Elsevier Science Ltd. All rights reserved.
A series of thiazole benzenesulfonamide-substituted 3-pyridylethanolamines was prepared and evaluated for their human beta(3) adrenergic receptor agonist activity. Incorporation of aryl and heteroaryl substitution in the 4-position of the thiazole ring resulted in a number of highly potent and selective beta(3) agonists. Results of preliminary in vivo evaluation of several of these compounds is described. (C) 2000 Elsevier Science Ltd. All rights reserved.
作者:Robert J Mathvink、J.Samuel Tolman、Dawn Chitty、Mari R Candelore、Margaret A Cascieri、Lawrence F Colwell、Liping Deng、William P Feeney、Michael J Forrest、Gary J Hom、D.Euan MacIntyre、Laurie Tota、Matthew J Wyvratt、Michael H Fisher、Ann E Weber
DOI:10.1016/s0960-894x(00)00390-5
日期:2000.9
A series of thiazole benzenesulfonamide-substituted 3-pyridylethanolamines was prepared and evaluated for their human beta(3) adrenergic receptor agonist activity. Incorporation of aryl and heteroaryl substitution in the 4-position of the thiazole ring resulted in a number of highly potent and selective beta(3) agonists. Results of preliminary in vivo evaluation of several of these compounds is described. (C) 2000 Elsevier Science Ltd. All rights reserved.